Cannulated Screw System + 04.354.342Recalls & reported problems
Tyber Medical, LLC · 3.5MM TI CANN SCREW + LT - 42MM · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00810040632594), received between Aug 28, 2024 and Aug 28, 2024 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Impaired Healing1
- Skin Infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryAug 28, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
TYBER MEDICAL BECAME AWARE OF AN ADVERSE EVENT AS PART OF A RETROSPECTIVE CLINICAL STUDY INTO OUR HEADED SCREW SYSTEM. PATIENT REPORTED TO CLINIC 4 WEEKS POST-OP WITH INFECTION AT THE SURGICAL SITES AND PRESCRIBED MEDICATION. PATIENT WAS RADIOGRAPHICALLY FUSED AT 3 MONTHS POST-OP. THE PATIENT RETURNED AT 4.5 MONTHS POST-OP WITH THE INFECTION PERSISTING. HARDWARE WAS REMOVED AT 4.5 MONTHS POST-OP. THE PATIENT FULLY HEALED FROM THE INFECTION AT THE 10 MONTH POINT. ADVERSE EVENT REPORTED FROM CLINIC: AT 4 WEEKS POST OPERATIVE THE PATIENT WAS PLACED ON CLINDAMYCIN 300MG TID FOR 10 DAYS DUE TO HISTORY OF DIABETES AND OPEN ULCERATIONS. THE EVENT WAS INTERMITTENT, MODERATE, SERIOUS, AND NOT LIFE THREATENING. THE ACTIONS TAKEN FOR THIS EVENT REQUIRED THERAPY AND THE PATIENT RECOVERED WITHOUT SEQUELAE. THIS EVENT WAS NOT RELATED TO THE TYBER MEDICAL TRAUMA SCREW SYSTEM. THE CLINDAMYCIN WAS DISCONTINUED, AND THE PATIENT WAS SENT TO WOUND CARE FOR ADDITIONAL FOLLOW-UP AND WOUND TREATMENT. THE PATIENT HAD A SECOND VISIT BECAUSE THEIR WOUNDS DID NOT HEAL WITH ASSISTANCE OF WOUND CARE. THE PATIENT WAS SUBSEQUENTLY BROUGHT BACK TO THE OR FOR REMOVAL OF HARDWARE, INCISION AND DRAINAGE, AND APPLICA
Patient problems: Impaired Healing; Skin Infection
MAUDE report 20085856 ↗
Other Screw, fixation, bone devices
- NA 03.043.029Synthes GmbH · Screw, fixation, bone503 reports
- OSTEORAPTOR 72201995Smith & Nephew, Inc. · Screw, fixation, bone253 reports
- Control 360 SK12Treace Medical Concepts, Inc. · Screw, Fixation, Bone195 reports
- HEALIX PEEK ORTHOCORD 222205Medos International Sàrl · Screw, fixation, bone186 reports
- PRECICE® Bone Transport System STP3.5-400Nuvasive Specialized Orthopedics, Inc. · Screw, Fixation, Bone3 recalls0 reports
- PRECICE® Bone Transport System STP3.5-225Nuvasive Specialized Orthopedics, Inc. · Screw, Fixation, Bone3 recalls0 reports
- PRECICE® Bone Transport System STP3.5-350Nuvasive Specialized Orthopedics, Inc. · Screw, Fixation, Bone3 recalls0 reports
- PRECICE® Bone Transport System STP3.5-300Nuvasive Specialized Orthopedics, Inc. · Screw, Fixation, Bone3 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page